对大血管血管炎的新治疗方法
Mahmut S Kaymakci1, Kenneth J Warrington1, Tanaz A Kermani2
1Division of Rheumatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA; email: kaymakci.mahmut@mayo.edu, warrington.kenneth@mayo.edu.
Annual review of medicine
|September 8, 2023
概括
巨细胞动脉炎 (GCA) 和塔卡亚苏动脉炎 (TAK) 是大型血管血管. 虽然治疗方法有所不同,但托西利祖马布作为一种有效的葡萄糖皮质醇节约剂对GCA和TAK都很有希望,改善缓解并可能限制血管损伤.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 血管医学 血管医学
背景情况:
- 巨细胞动脉炎 (GCA) 和塔卡亚苏动脉炎 (TAK) 是不同的大血管血管,影响大动脉及其分支.
- 这些情况可能导致严重的缺血并发症,动脉瘤和剖析,需要有效的管理策略.
- 目前的治疗方法,主要是葡萄糖皮质类药物,与频繁的复发和显著的毒性有关,突出显示了对替代疗法的需要.
研究的目的:
- 为了比较各种治疗剂在管理GCA和TAK方面的疗效.
- 评估包括生物制剂在内的新型向疗法的作用,以改善患者的治疗结果.
- 强调了解疾病发病因子对于未来治疗开发的重要性.
主要方法:
- 审查关于GCA和TAK管理的当前文献.
- 对葡萄糖皮质激素,常规免疫抑制剂,TNF抑制剂和tocilizumab的治疗结果的分析.
- 在GCA和TAK患者之间的治疗反应的比较.
主要成果:
- 葡萄糖皮质类药物是标准的,但导致常见的复发和毒性.
- 传统的免疫抑制剂在TAK中显示出益处,但它们在GCA中的作用尚不确定.
- TNF抑制剂在TAK中有效,但在GCA中无效;托西利祖马布在GCA和TAK中有效,作为一种葡萄糖皮质激素节约剂.
结论:
- 托西利祖马布作为GCA的批准葡萄糖皮质醇节约生物药物,代表了显著的进步,并且在TAK中显示出有效性.
- 向治疗提供了改善的缓解率,并可能减少大血管血管的血管损伤.
- 对病原体的进一步研究对于开发更有效和个性化的GCA和TAK治疗方法至关重要.
更多相关视频
相关概念视频
01:27Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
01:29Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
01:14Myocarditis III: Medical Management
7
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
7
01:29Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152
01:27Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
01:17Pericarditis III: Medical Management
13
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
13